Flexibility is key for processing sector says Millipore
Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs